Vanguard Group Inc Atara Biotherapeutics, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,012,938 shares of ATRA stock, worth $42.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,012,938

Previous 6,686,043 25.02%

Holding current value

$42.6 Million

Previous $3.41 Million 1.44%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.44 - $1.22 $736,166 - $2.04 Million	-1,673,105 Reduced 25.02%	5,012,938 $3.46 Million
Q4 2023 Feb 14, 2024	BUY	$0.23 - $1.74 $18,425 - $139,391	80,110 Added 1.21%	6,686,043 $3.41 Million
Q3 2023 Nov 14, 2023	SELL	$1.41 - $2.31 $479,961 - $786,319	-340,398 Reduced 4.9%	6,605,933 $9.78 Million
Q2 2023 Aug 14, 2023	BUY	$1.5 - $3.04 $136,717 - $277,080	91,145 Added 1.33%	6,946,331 $11.2 Million
Q1 2023 May 15, 2023	SELL	$2.8 - $5.46 $996,413 - $1.94 Million	-355,862 Reduced 4.93%	6,855,186 $19.9 Million

Q4 2022 Feb 10, 2023	BUY	$2.85 - $5.18 $1.72 Million - $3.13 Million	604,539 Added 9.15%	7,211,048 $23.7 Million
Q3 2022 Nov 14, 2022	SELL	$2.85 - $8.73 $1.97 Million - $6.04 Million	-691,564 Reduced 9.48%	6,606,509 $25 Million
Q2 2022 Aug 12, 2022	BUY	$4.69 - $9.84 $1.81 Million - $3.79 Million	385,499 Added 5.58%	7,298,073 $56.9 Million
Q1 2022 May 13, 2022	SELL	$8.44 - $16.89 $1.38 Million - $2.75 Million	-162,947 Reduced 2.3%	6,912,574 $64.2 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $19.89 $4.04 Million - $5.47 Million	274,938 Added 4.04%	7,075,521 $112 Million
Q3 2021 Nov 12, 2021	BUY	$11.99 - $17.9 $1.16 Million - $1.73 Million	96,442 Added 1.44%	6,800,583 $122 Million
Q2 2021 Aug 13, 2021	BUY	$12.89 - $16.58 $86.4 Million - $111 Million	6,704,141 New	6,704,141 $104 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $802M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Atara Biotherapeutics, Inc. Transaction History